Most cases were reported as serious (62.3%), citing ‘other medically important condition’ as the primary reason for seriousness (58.6%), and 68.8% of all cases involved cannabis extracts. Causality was assessed for 668 events; most were assessed as being ‘possibly’ associated with the reported cannabis product.